By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Imprimis Pharmaceuticals 

12264 El Camino Real
Suite 350
San Diego  California  92130-0001  U.S.A.
Phone: 858-704-4040 Fax: 858-345-1745


Key Statistics

Ownership: Public

Web Site: Imprimis
Symbol: immy

Company News
Imprimis (immy) Announces Second Quarter 2016 Financial Results 8/16/2016 11:31:42 AM
Imprimis (immy) Strengthens Senior Leadership Team With Key Hires In Operations, Quality, Manufacturing And Client Relations 8/15/2016 9:58:53 AM
Imprimis (immy) Announces $2 Million Equipment Sale Leaseback Agreement With Essex Capital Corporation 8/11/2016 6:46:25 AM
Imprimis (immy) To Host Its Second Quarter 2016 Financial Report Conference Call And Webcast On August 15, 2016 At 4:30 P.M. EDT 8/1/2016 10:03:02 AM
Imprimis (immy) Launches New MaxRx Prescriber Portal 7/29/2016 7:57:30 AM
Imprimis (immy) Release: Peer-Reviewed Study Of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared To Drops 7/22/2016 12:20:17 PM
Imprimis (immy) To Present At 6th Annual LD Micro Invitational On June 8, 2016 6/3/2016 9:53:13 AM
Imprimis (immy) To Present At The Jefferies 2016 Healthcare Conference 6/1/2016 1:27:11 PM
Imprimis (immy) Announces First Quarter 2016 Financial Results And Provides Business Update 5/13/2016 6:29:29 AM
Clinical Study of Imprimis (immy)' Tri-Moxi-Vanc Dropless Therapy Formulation Show Statistically Significant Reduction In Cystoid Macular Edema In Patients Following Cataract Surgery 5/12/2016 6:59:39 AM